Showing 35,661 - 35,680 results of 69,884 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.36s Refine Results
  1. 35661
  2. 35662
  3. 35663
  4. 35664
  5. 35665
  6. 35666
  7. 35667
  8. 35668
  9. 35669
  10. 35670

    mRNA expression of Sirt3 and SOD2 in the auditory cortex. by Lingling Zeng (519902)

    Published 2014
    “…Both gene expressions were significantly decreased with age. *Significantly different from the NS groups (*P<0.05, **P<0.01). …”
  11. 35671

    Tolerance regions for parameters based on the comparison of the model to itself using the composite cost function. by Thomas Nowotny (146275)

    Published 2013
    “…Parameters were tested up to a 10 fold increase and 10 fold decrease. The parameters are ordered in increasing tolerance for <i>I<sub>DC</sub></i> = 0 <i>nA</i> (B). …”
  12. 35672

    MRI results in triple-vessel protocol. by Eleni Tseliou (523870)

    Published 2016
    “…Ejection fraction (EF) decreased significantly in the placebo group compared to both CDC-treated groups (p = 0.1 placebo vs CDCs stop-flow and p = 0.05 placebo vs CDCs continuous-flow). …”
  13. 35673

    CMV DNAemia specific protein signatures exist pre-CMV DNAemia timepoint and post-CMV. by Tara K. Sigdel (9386207)

    Published 2023
    “…The significance of the changes is demonstrated by a Volcano plot. The most significantly increased protein was Lysine Methyltransferase 2C (KMT2C) with 3.38 fold increase (p = 0.05) in CMV DNAemia positive samples and most significantly decreased protein was Immunoglobulin Lambda Variable 7–43 (IGLV7-43) with 2.17 fold decrease (p = 0.01). …”
  14. 35674

    Microarchitectural quantitative analysis results of an ROI in the femur trabecular bone. by Bin Jia (372751)

    Published 2014
    “…**<i>P<</i>0.01vs. C, ##<i>P<</i>0.01vs.HLU, <sup>△△</sup><i>P<</i>0.01vs.BL, <sup>△</sup><i>P<</i>0.05vs.BL.…”
  15. 35675
  16. 35676
  17. 35677

    Protocol: Temporary Pacemaker Verification and Troubleshooting by Jill Ley (4090672)

    Published 2022
    “…<p>(Figure 1)</p> <p>(Figure 2)</p> <p><strong>Determining the Stimulation Threshold</strong></p> <ul> <li>NOTE: a paced rhythm must be present and patient stable</li> <li>From 100% pacing, gradually decrease output for A or V, while watching monitor until you lose capture</li> <li>Now gradually increase output until 1:1 capture returns – this is the stimulation threshold</li> <li>This is the lowest amount of energy that will reliably capture the heart and pace</li> <li>Set mA 1.5-3 times above this threshold value for safety</li> <li>Repeat for other circuit (A or V)</li> <li>Note: the stimulation threshold should be checked DAILY by the MD/NP when pacing is in use; in the event 
the threshold value is rising, discuss with surgeon to determine if alternative pacing system is needed</li> </ul> <p><strong>Determining the Sensing Threshold</strong></p> <ul> <li>Note: the patient must have an underlying rhythm and tolerate a brief period without pacing to perform</li> <li>Set RATE at least 10 bpm below patient’s intrinsic heart rate (to allow sensing)</li> <li>Set OUTPUT at 0.1 mA (to avoid competitive pacing when device is made asynchronous briefly)</li> <li>Highlight SENSITIVITY (under Menu 1)</li> <li>Decrease SENSITIVITY: Slowly turn dial counter-clockwise until pace indicator flashes regularly (asynchronously)</li> <li>Increase SENSITIVITY: Slowly turn dial clockwise until sense indicator flashes again (when sensing resumes, this is the sensing threshold – the smallest complex that is reliably recognized, thus inhibiting the device)</li> <li>Set SENSITIVITY < half this threshold value for safety</li> <li>Repeat for other circuit (A or V)</li> <li>Restore previous rate and output values</li> </ul> <p><strong>Rapid Atrial (Overdrive) Pacing – PERFORMED BY MD/NP/CNS ONLY</strong></p> <ul> <li>Used to “overdrive pace” and terminate some atrial reentrant tachyarrhythmias, especially atrial flutter</li> <li>ALWAYS VERIFY correct wire connections to avoid stimulating the ventricles at a rapid rate!…”
  18. 35678

    Inhibitors of K<sup>+</sup> channels have an opposite effect on HR-/LR-astrocytes when applied during OGD. by Jana Benesova (155548)

    Published 2012
    “…<b>A–C bottom:</b> The effect of inhibitors was evaluated in each individual cell and expressed as the percent cell volume increase/decrease related to the maximal volume after 20-minute OGD, which was set as 0%. …”
  19. 35679
  20. 35680